University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 1B-12-9


An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with Her2 Positive (Her2+) Metastatic Breast Cancer.

Type: Observational
Phase: Observational
Status: Open to Accrual
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Debasish Tripathy, M.D.
Other Trial Staff:  Kristy Watkins, R.N., Nancy Perez, R.N., Yvonne Flores, D.M., Margarita Carranza, D.M., Jessica Levano, R.N.

Staff may log in to see study documents.


You may participate in this study if:
 Requirement
1Initial diagnosis of HER2+ metastatic breast cancer, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
2Availability of cancer-specific historical data points in the patient's medical records
3Signed Informed Consent form
4Signed Authorization for the Use and Disclosure of Health Information form





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.